Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients

Diabetes

Volumn 43, Issue 3, 1994, Pages 369-374

  Jabri, Nabeel ^a   Schalch, Don S ^a   Schwartz, Sherwyn L ^b   Fischer, Jerome S ^b   Kipnes, Mark S ^b   Radnik, Barbara J ^b   Turman, Nancy J ^a   Marcsisin, Victoria S ^c   Guler, Hans Peter ^c  

^a University of Wisconsin Health   (United States)

^b Diabetes and Glandular Disease Research Center   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPHANE INSULIN; RECOMBINANT SOMATOMEDIN C;

ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DYSPNEA; EDEMA; FACE EDEMA; FATIGUE; FEMALE; FLUSHING; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INJECTION SITE; INSULIN RESISTANCE; INSULIN TREATMENT; MALE; MYALGIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RASH; SUBCUTANEOUS DRUG ADMINISTRATION; TACHYCARDIA; WEIGHT GAIN;

EID: 0028118369     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.43.3.369     Document Type: Article

References (27)

1. DeFronzo RA, Ferranini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-94, 1991
2. Reaven G: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1989
3. Kaplan NM: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 149:1514-20, 1989
4. Bach LA, Rechler MM: Insulin-like growth factors and diabetes. Diabetes Metab Rev 8:229-57, 1992
5. Turkalj I, Keller U, Ninnis R, Vosmeer S, Stauffacher W: Effect of increasing doses of rhIGF-I on glucose, lipid, and leucine metabolism in man. J Clin Endocrinol Metab 75:1186-91, 1992
6. Rennert NJ, Caprio S, Sherwin RS: IGF-I inhibits glucose stimulated insulin secretion but does not impair glucose metabolism in normal humans. J Clin Endocrinol Metab 76:804-806, 1993
7. Boulware SD, Tamborlane WV, Sherwin RS: Diverse effects of insulin-like growth factor I on glucose, lipid and amino acid metabolism. Am J Physiol 262:E130-33, 1992
8. Rosetti L, Frontoni S, Dimarchi R, DeFronzo RA, Giaccari A: Metabolic effects of IGF-I in diabetic rats. Diabetes 40:444-48, 1991
9. Jacob RJ, Sherwin RS, Bowen L, Fryburg D, Fagin KD, Tamborlane WV, Shulman GI: Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats. Am J Physiol 260:E262-68, 1991
10. Kerr D, Tamborlane WV, Rife F, Sherwin RS: Effect of insulin-like growth factor I on the responses to and recognition of hypoglycemia in humans: a comparison with insulin. J Clin Invest 91:141-47, 1993
11. Zenobi PD, Graf S, Ursprung H, Froesch ER: Effects of insulin-like growth factor I on glucose tolerance, insulin levels and insulin secretion. J Clin Invest 89:1908-13, 1992
12. Zenobi PD, Jaeggi-Groisman SE, Riesen WF, Roder ME, Froesch ER: Insulin-like growth factor I improves glucose and lipid metabolism in type II diabetes mellitus. J Clin Invest 90:2234-41, 1992
13. Schalch DS, Turman NJ, Marcsisin VS, Heffernan M, Guler H-P: Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitus. J Clin Endocrinol Metab 77:1563-68, 1993
14. Schoenle EJ, Zenobi PD, Torresani T, Werder EA, Zachman M, Froesch ER: RhIGF-I reduces hyperglycemia in patients with extreme insulin resistance. Diabetologia 34:675-79, 1991
15. Quin JD, Fisher BM, Paterson KR, Inoue A, Beastall GH, MacCuish AC: Acute response to rhIGF-I in a patient with Mendenhall's syndrome. N Engl J Med 323:1425-26, 1990
16. Usala AL, Madigan T, Burguera B, Sinha MK, Caro JF, Cunningham P, Powell JG, Butler BC: Brief report: treatment of insulin resistant diabetic ketoacidosis with insulin like growth factor I in an adolescent with insulin dependent diabetes. N Engl J Med 327:853-57, 1992
17. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR: Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 91:391-96, 1993
18. Lehmann S, Cerra FB: Growth hormone and nutritional support: adverse metabolic effects. Nutr Clin Pract 7:27-30, 1992
19. Salomon F, Cuneo RC, Hesp R, Sonksen PH: The effect of treatment with rhGH on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803, 1989
20. Ebeling PR, Jones JD, O'Fallon WM, Janes CH, Riggs BL: Short-term effects of rhIGF-I on bone turnover in normal women. J Clin Endocrinol Metab 77:1384-87, 1993
21. Hirschberg R, Brunori G, Kopple JD, Guler HP: Effects of IGF-I on renal function in normal men. Kidney Int 43:387-97, 1993
22. Merimee TJ, Zapf J, Froesch ER: Insulin-like growth factors - studies in diabetics with and without retinopathy. N Engl J Med 309:527-30, 1983
23. Grant M, Russell B, Fitzgerald C, Merimee TJ: Insulin-like growth factors in vitreous: studies in control and diabetic subjects with neovascularization. Diabetes 35:416-20, 1986
24. Hussain MA, Studer K, Messmer EP, Froesch ER: Changes in the blood retinal barrier under treatment with IGF-I in healthy men (Abstract 3). In Fourth International Symposium on Insulin, IGF's and Their Receptors, Woodshole MA, 1993 American Diabetes Association, Alexandria, VA
25. Morrow L, O'Brien M, Molles D, Flier J, Moses A: Recombinant human (rh)IGF-I improves hyperglycemia and insulin sensitivity in severe insulin resistance (Abstract 47). In Fourth International Symposium on Insulin, IGF's and Their Receptors, Woodshole MA, 1993 American Diabetes Association, Alexandria, VA
26. Kuzuya H, Mtsuura N, Sakamoto M, Makino H, Sakamoto Y, Kadowaki T, Suzuki Y, Kobayashi M, Akasawa Y, Nomura M, Yoshimasa Y, Kasuga M, Goji K, Nagataki S, Oyasu H, Imura H: Trial of IGF-I therapy for patients with extreme insulin resistance syndromes. Diabetes 42:696-705, 1993
27. Guler HP, Zapf J, Froesch ER: Short-term metabolic effects of rhIGF-I in healthy adults. N Engl J Med 317:137-40, 1987